A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries.
Muhammad Daoud ButtSiew Chin OngAzra RafiqMuhammad Nasir KalamAhsan SajjadMuhammad AbdullahTooba MalikFatima YaseenZaheer Ud-Din BabaarPublished in: Journal of pharmaceutical policy and practice (2024)
This study revealed substantial heterogeneity in diabetes treatment costs; some could be reduced by improving data collection, analysis, and reporting procedures. Diabetes is an expensive disease to treat in low- and middle-income countries, and attaining Universal Health Coverage should be a priority for the global health community.
Keyphrases
- global health
- glycemic control
- public health
- type diabetes
- mental health
- healthcare
- cardiovascular disease
- single cell
- physical activity
- electronic health record
- health information
- metabolic syndrome
- deep learning
- affordable care act
- insulin resistance
- risk assessment
- human health
- skeletal muscle
- health insurance
- replacement therapy